Imberti, Jacopo Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.148
NA - Nord America 5.504
EU - Europa 2.641
SA - Sud America 947
OC - Oceania 254
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.622
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.333
SG - Singapore 2.047
CN - Cina 1.867
IT - Italia 768
BR - Brasile 740
HK - Hong Kong 722
VN - Vietnam 606
GB - Regno Unito 353
FI - Finlandia 305
KR - Corea 299
DE - Germania 270
AU - Australia 252
SE - Svezia 229
RU - Federazione Russa 194
FR - Francia 137
ID - Indonesia 98
IN - India 91
AR - Argentina 78
MX - Messico 71
CA - Canada 69
BD - Bangladesh 60
NL - Olanda 58
IQ - Iraq 40
JP - Giappone 40
TR - Turchia 40
AE - Emirati Arabi Uniti 38
ZA - Sudafrica 38
PL - Polonia 37
AT - Austria 35
PK - Pakistan 35
UA - Ucraina 32
BG - Bulgaria 31
LT - Lituania 31
CO - Colombia 30
ES - Italia 30
EC - Ecuador 27
UZ - Uzbekistan 22
MA - Marocco 20
VE - Venezuela 20
CL - Cile 19
EG - Egitto 18
IE - Irlanda 18
KE - Kenya 16
RS - Serbia 16
TH - Thailandia 16
AZ - Azerbaigian 13
MY - Malesia 13
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
RO - Romania 12
DZ - Algeria 11
PY - Paraguay 11
TW - Taiwan 11
BE - Belgio 10
TN - Tunisia 10
BO - Bolivia 9
JO - Giordania 9
OM - Oman 9
KZ - Kazakistan 8
HU - Ungheria 7
NP - Nepal 7
PE - Perù 7
PH - Filippine 7
PT - Portogallo 7
AL - Albania 6
CH - Svizzera 6
GE - Georgia 6
CU - Cuba 5
DO - Repubblica Dominicana 5
IL - Israele 5
IR - Iran 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
BY - Bielorussia 4
CR - Costa Rica 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
CY - Cipro 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
LB - Libano 2
MT - Malta 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
Totale 15.602
Salva come PNG Salva come JPEG
Città #
Singapore 1.277
Santa Clara 948
Hefei 931
Ashburn 731
Hong Kong 714
San Jose 479
Seoul 299
Helsinki 246
Fairfield 236
Beijing 233
Chandler 220
London 211
Ho Chi Minh City 196
Nyköping 180
Perth 167
New York 157
The Dalles 153
Los Angeles 141
Hanoi 133
Chicago 107
Council Bluffs 97
Woodbridge 95
Houston 93
Munich 90
Dallas 88
Seattle 82
Wilmington 77
Bologna 75
Cambridge 72
Lauterbourg 71
São Paulo 71
Jakarta 69
Milan 69
Shanghai 67
Buffalo 57
Kent 52
Moscow 51
Modena 48
San Diego 47
Rome 46
Salt Lake City 46
Lappeenranta 39
Sydney 38
Mexico City 37
Princeton 37
Frankfurt am Main 35
Ann Arbor 34
Orem 34
Da Nang 33
Tokyo 33
Haiphong 29
Sofia 29
Warsaw 26
Schiffdorf 25
Southend 25
Johannesburg 24
Amsterdam 23
Redondo Beach 23
Atlanta 22
Nuremberg 21
Tashkent 20
Toronto 20
Guangzhou 19
Montreal 19
Rio de Janeiro 19
Turin 19
Turku 19
Vienna 19
Dublin 18
Parma 18
Stockholm 18
Düsseldorf 17
Baghdad 16
Denver 16
Portsmouth 16
Campinas 15
Chennai 15
Hải Dương 15
Kilburn 15
Naples 15
Belo Horizonte 14
Biên Hòa 14
Brooklyn 14
Elk Grove Village 14
Columbus 13
Melbourne 13
Porto Alegre 13
Belgrade 12
Boston 12
Curitiba 12
Mumbai 12
Nairobi 12
Phoenix 12
Tampa 12
Ankara 11
Baku 11
Boardman 11
Brasília 11
Istanbul 11
Paris 11
Totale 10.382
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 487
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 309
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 294
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 247
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 236
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 236
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 228
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 222
Progression of Atrial Fibrillation after Cryoablation 211
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 208
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 208
Remote monitoring and telemedicine in heart failure: implementation and benefits 208
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 206
Atrial fibrillation burden: Stepping beyond the categorical characterization 201
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 195
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 194
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 187
What do we do about atrial high rate episodes? 187
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 185
Female sex and stroke in atrial fibrillation: an intriguing relationship 185
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 177
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 177
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 173
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 172
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 171
Single-lead VDD pacing: a literature review on short-term and long-term performance 170
Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients 169
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 168
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 167
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 165
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 165
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 161
Atrial fibrillation in pneumonia: what clinical implications at long-term? 160
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 160
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 158
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 156
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 153
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 152
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 150
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 149
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 149
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 147
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 146
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 145
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis 145
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 145
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 144
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 141
Clinical decisions for appropriate management of patients with atrial fibrillation 140
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 140
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 137
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 137
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 133
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 132
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 131
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 130
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 130
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil 128
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry 127
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation 124
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 123
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe 123
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 122
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 122
The epidemiology and mortality of patients with atrial fibrillation: a complex landscape 121
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation 118
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 118
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 118
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 117
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation 116
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients 115
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 111
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 108
Antiarrhythmic drugs in the era of atrial fibrillation ablation 108
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 107
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 105
Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations? 105
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 103
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 103
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 102
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex 100
Mobile health technology in atrial fibrillation 100
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 99
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 99
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 97
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry 97
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 96
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 95
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? 94
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients 93
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome 93
Length of hospital stay for elective electrophysiological procedures: a survey from the European Heart Rhythm Association 92
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions 92
Access to implantable cardioverter defibrillator therapy within and across countries: the barriers still persist 90
Atrial fibrillation screening: The importance of the patient perspective 87
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 83
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? 80
New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development 76
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 73
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke 69
Totale 14.728
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 0 0 0 0 0 0 42 24 27
2021/2022667 52 76 14 24 25 43 18 38 68 42 126 141
2022/2023835 88 92 81 50 64 110 29 90 94 19 73 45
2023/20241.088 18 55 67 110 240 141 88 132 18 37 57 125
2024/20254.367 74 58 264 230 616 564 407 263 420 285 633 553
2025/20268.241 679 430 805 1.129 975 476 1.306 537 1.128 776 0 0
Totale 15.776